Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29,881,634
-
Total 13F shares
-
8,673,835
-
Share change
-
+419,186
-
Total reported value
-
$174,440,609
-
Put/Call ratio
-
65%
-
Price per share
-
$20.14
-
Number of holders
-
52
-
Value change
-
+$8,178,699
-
Number of buys
-
24
-
Number of sells
-
24
Institutional Holders of Profound Medical Corp. - Common Shares (PROF) as of Q1 2021
As of 31 Mar 2021 Profound Medical Corp. - Common Shares (PROF) had 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,673,835 shares of stock of the company.
Largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Redmile Group, LLC, FIL Ltd, LETKO, BROSSEAU & ASSOCIATES INC, GAGNON SECURITIES LLC, PURA VIDA INVESTMENTS, LLC, ROYCE & ASSOCIATES LP, Blackcrane Capital, LLC, AWM Investment Company, Inc., and Gagnon Advisors, LLC.
This table shows 52 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.